Aminologics Co.,Ltd. (KOSDAQ:074430)
South Korea · Delayed Price · Currency is KRW 1,179.00
-1.00 (-0.08%)
At close: Sep 3, 2026
Aminologics Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 99,158 | 104,865 | 78,869 | 118,039 | 160,723 | 192,780 | |
Market Cap Growth | 10.15% | 32.96% | -33.18% | -26.56% | -16.63% | -18.40% |
Enterprise Value | 62,763 | 56,652 | 46,111 | 94,826 | 132,066 | 168,532 |
Last Close Price | 1125.00 | 1194.00 | 898.00 | 1344.00 | 1830.00 | 2195.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 31.28 | 29.78 | - | 48.45 | - | 35.97 |
PS Ratio | 3.79 | 4.76 | 4.70 | 5.65 | 5.88 | 8.44 |
PB Ratio | 1.70 | 1.87 | 1.53 | 2.17 | 3.13 | 3.25 |
P/TBV Ratio | 1.76 | 1.94 | 1.62 | 2.34 | 3.40 | 4.61 |
P/FCF Ratio | 58.74 | 42.03 | 11.34 | - | 33.94 | 459.21 |
P/OCF Ratio | 56.22 | 41.28 | 10.56 | - | 30.75 | 206.07 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.40 | 2.57 | 2.75 | 4.54 | 4.83 | 7.38 |
EV/EBITDA Ratio | 10.53 | 13.87 | - | 49.70 | 18.19 | 39.82 |
EV/EBIT Ratio | 11.45 | 15.76 | - | 64.86 | 19.12 | 42.63 |
EV/FCF Ratio | 37.18 | 22.71 | 6.63 | - | 27.89 | 401.45 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.29 | 0.29 | 0.04 | 0.03 | 0.04 | 0.03 |
Debt / EBITDA Ratio | 2.83 | 3.97 | - | 0.95 | 0.27 | 0.39 |
Debt / FCF Ratio | 9.98 | 6.50 | 0.29 | - | 0.42 | 3.94 |
Net Debt / Equity Ratio | -0.62 | -0.84 | -0.64 | -0.49 | -0.53 | -0.40 |
Net Debt / EBITDA Ratio | -6.11 | -11.46 | 19.77 | -13.98 | -3.75 | -5.67 |
Net Debt / FCF Ratio | -21.56 | -18.77 | -4.80 | 71.35 | -5.75 | -57.19 |
Asset Turnover | 0.30 | 0.31 | 0.29 | 0.37 | 0.45 | 0.37 |
Inventory Turnover | 2.35 | 2.32 | 1.91 | 1.61 | 1.98 | 2.39 |
Quick Ratio | 1.99 | 2.57 | 9.22 | 13.84 | 10.17 | 5.98 |
Current Ratio | 2.28 | 2.85 | 10.71 | 16.96 | 12.71 | 7.19 |
Return on Equity (ROE) | 5.58% | 6.54% | -3.05% | 4.61% | -13.14% | 9.49% |
Return on Assets (ROA) | 3.88% | 3.19% | -2.35% | 1.61% | 7.15% | 3.94% |
Return on Capital Employed (ROCE) | 9.30% | 6.30% | -4.10% | 2.70% | 13.20% | 6.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 3.19% | 3.36% | -2.05% | 2.06% | -4.53% | 2.78% |
FCF Yield | 1.70% | 2.38% | 8.82% | -0.32% | 2.95% | 0.22% |
Buyback Yield / Dilution | 2.42% | 2.42% | -2.48% | - | - | - |